• Study of NNC0519-0130 and semaglutide in people with chronic kidney disease who are overweight or obese, with or without type 2 diabetes

    Not recruiting

    2 1 1
    Investigated Drugs:
    Bulgaria Italy Poland Spain
  • Study on Abemaciclib, Letrozole, and Fulvestrant for Patients with Advanced HR-positive/HER2-negative Breast Cancer

    Not recruiting

    2 1 1 1
    Italy Portugal Spain
  • Study on Treating Metastatic Castration-Resistant Prostate Cancer with 177Lu-PNT2002 Compared to Abiraterone or Enzalutamide for Patients After Hormonal Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    France The Netherlands Sweden
  • Study of Isatuximab, Pomalidomide and Dexamethasone combination for multiple myeloma patients who previously received Lenalidomide and Proteasome Inhibitor therapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Greece
  • Study on Cannabidiol for Reducing Alcohol Consumption in Patients with Alcohol Use Disorder

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study of Atropine Sulfate eye drops (0.

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Hungary Ireland Poland Slovakia Spain
  • Study on Tezepelumab for Patients with Severe Asthma

    Not recruiting

    3 1 1
    Investigated Drugs:
    France
  • Study on the Safety and Effects of LY3372689 in Patients with Early Alzheimer’s Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    Poland
  • Study on the Safety and Effects of RP-1664 for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark
  • Study of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium Bulgaria Czechia Denmark Finland France +8

powered by